In vivo catabolism of α1-antichymotrypsin is mediated by the Serpin receptor which binds α1-proteinase inhibitor, antithrombin III and heparin cofactor II-Reference-Cited by-同舟云学术

In vivo catabolism of α1-antichymotrypsin is mediated by the Serpin receptor which binds α1-proteinase inhibitor, antithrombin III and heparin cofactor II

Published:1988-11 Issue:2 Volume:967 Page:158-162
ISSN:0304-4165
Container-title:Biochimica et Biophysica Acta (BBA) - General Subjects
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - General Subjects

Author:

Pizzo Salvatore V.,Mast Alan E.,Feldman Steven R.,Salvesen Guy

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference20 articles.

1. α1-Antitrypsin and the serpins: variation and countervariation

2. HUMAN PLASMA PROTEINASE INHIBITORS

3. In vivo catabolism of α1-proteinase inhibitor-trypsin, antithrombin III-thrombin and α2-macroglobulin-methylamine

4. In vivo catabolism of heparin cofactor II and its complex with thrombin: Evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors

5. A Unique Pathway for the Plasma Elimination of α2-Antiplasmin-Protease Complexes in Mice

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kallikrein-related peptidase 14 is the second KLK protease targeted by the serpin vaspin;Biological Chemistry;2018-09-25

2. Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery;Thrombosis and Haemostasis;2018-08-07

3. Changes in fPSA level could discriminate tPSA flare-up from tPSA progression in patients with castration-refractory prostate cancer during the initial phase of docetaxel-based chemotherapy;Cancer Chemotherapy and Pharmacology;2013-09-17

4. Rapid elimination kinetics of free PSA or human kallikrein-related peptidase 2 after initiation of gonadotropin-releasing hormone-antagonist treatment of prostate cancer: potential for rapid monitoring of treatment responses;Clinical Chemistry and Laboratory Medicine (CCLM);2012-07-05

5. Targeting Free Prostate-Specific Antigen forIn VivoImaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone;Cancer Biotherapy and Radiopharmaceuticals;2012-05